Stockscreener 앱 받기
9.16
0.11%
-0.010
전일 마감가:
$9.17
열려 있는:
$9.14
하루 거래량:
29,551
Relative Volume:
0.31
시가총액:
$92.16M
수익:
$75.67M
순이익/손실:
$-31.15M
주가수익비율:
-32.99
EPS:
-0.2777
순현금흐름:
$-39.79M
1주 성능:
+0.66%
1개월 성능:
+0.11%
6개월 성능:
-21.71%
1년 성능:
-31.71%
1일 변동 폭
$9.14
$9.22
1주일 범위
$9.09
$9.28
52주 변동 폭
$4.815
$20.02
Optinose Inc Stock (OPTN) Company Profile
명칭
Optinose Inc
전화
267-364-3500
주소
777 TOWNSHIP LINE ROAD, YARDLEY, PA
OPTN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OPTN
Optinose Inc
|
9.16 | 92.16M | 75.67M | -31.15M | -39.79M | -0.2777 |
|
ZTS
Zoetis Inc
|
146.85 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.19 | 45.61B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.93 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.31 | 15.25B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.25 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Optinose Inc Stock (OPTN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-20 | 다운그레이드 | Lake Street | Buy → Hold |
| 2025-01-03 | 재확인 | H.C. Wainwright | Buy |
| 2024-03-11 | 개시 | H.C. Wainwright | Buy |
| 2023-08-21 | 개시 | Lake Street | Buy |
| 2022-10-21 | 재개 | Jefferies | Buy |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2019-12-18 | 개시 | Cowen | Outperform |
| 2018-08-08 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Optinose Inc 주식(OPTN)의 최신 뉴스
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: The AZEK Company Inc. (NYSEAZEK), Mesa Air Group, Inc. (NasdaqMESA), Mr. Cooper Group Inc. (Nasdaq – COOP), Optinose, Inc. (NasdaqOPTN) - Morningstar
After Fielding Multiple Offers, Yardley-Based Optinose Secures Potential $330M Deal With Paratek - BUCKSCO.Today
How a Bucks County firm's multiyear pursuit of a partner led to a potential $330M deal - The Business Journals
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COOP, MESA on Behalf of Shareholders - The Malaysian Reserve
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Intranasal Drug Delivery Devices Market Projected To Witness - openPR.com
When (OPTN) Moves Investors should Listen - news.stocktradersdaily.com
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The MergerOPTN, SLRN, AKYA, SHYF - Lelezard
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN - Bluefield Daily Telegraph
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN, SLRN, AKYA, SHYF - GlobeNewswire Inc.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HMST, COOP, OPTN, RDFN on Behalf of Shareholders - The Malaysian Reserve
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Mr. Cooper Group Inc. (Nasdaq – COOP), Beacon Roofing Supply, Inc. (NasdaqBECN), Optinose, Inc. (NasdaqOPTN), Redfin Corporation (NasdaqRDFN - TradingView
Bank of New York Mellon Corp Sells 170,507 Shares of OptiNose, Inc. (NASDAQ:OPTN) - Defense World
Optinose Reports 2024 Financial Results, Highlights Prescription Growth and First Operational Income - MyChesCo
OptiNose (OPTN) Reports Q4 Loss, Tops Revenue Estimates - MSN
OptiNose earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights - GlobeNewswire
OptiNose: Q4 Earnings Snapshot - The Washington Post
OPTINOSE Earnings Results: $OPTN Reports Quarterly Earnings - Nasdaq
OptiNose Q4 Net Loss Narrows - Nasdaq
OptiNose Q4 Income From Operations USD 354 Thousand - MarketScreener
OptiNose Inc. Q4 Loss Decreases, Beats Estimates - Nasdaq
Philly weekly roundup: Proscia's $50M raise; Optinose acquired; A new biotech startup incubator - Technical.ly
Wall Street Analysts Believe OptiNose (OPTN) Could Rally 143.06%: Here's is How to Trade - Yahoo Finance
Paratek Pharmaceuticals’ Acquisition of Optinose - Global Legal Chronicle
Piper Sandler Reaffirms Neutral Rating for OptiNose (NASDAQ:OPTN) - Defense World
HC Wainwright Reaffirms Neutral Rating for OptiNose (NASDAQ:OPTN) - Defense World
OptiNose (NASDAQ:OPTN) Cut to “Hold” at Piper Sandler - Defense World
OptiNose (NASDAQ:OPTN) Rating Lowered to “Hold” at Lake Street Capital - Defense World
OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of OptiNose, Inc.OPTN - Business Wire
Earnings To Watch: OptiNose Inc (OPTN) Reports Q4 2024 Result - GuruFocus
OPTN Stock Soars 53% on Inking $330M Deal to be Acquired by Paratek - MSN
Paratek Pharmaceuticals Acquires Yardley-Based Optinose in $330M Deal - BUCKSCO.Today
This FedEx Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga
Further Upside For OptiNose, Inc. (NASDAQ:OPTN) Shares Could Introduce Price Risks After 56% Bounce - Simply Wall St
Why OptiNose Inc. (OPTN) Surged On Thursday? - Insider Monkey
ProAssurance (PRA) and Optinose (OPTN) soar on M&A news - Investorsobserver
Darden Restaurants, Nike, Optinose - TradingView
Optinose Shares Soar After Merger Agreement With Paratek Pharmaceuticals: Retail Sentiment Takes Flight - Asianet Newsable
10 Micro-, Small-Cap Firms Dominate Thursday’s Gains - Insider Monkey
Lake Street cuts Optinose stock rating, lowers target to $9 By Investing.com - Investing.com Australia
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of OptiNose, Inc.OPTN - The Malaysian Reserve
Paratek To Acquire Optinose, Expanding Portfolio Beyond Antibiotics - insights.citeline.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRA, BECN, OPTN on Behalf of Shareholders - The Malaysian Reserve
Sector Update: Health Care Stocks Mixed in Afternoon Trading -March 20, 2025 at 02:03 pm EDT - Marketscreener.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Beacon Roofing Supply, Inc. (Nasdaq – BECN), Optinose, Inc. (Nasdaq – OPTN), Corporation (Nasdaq – RDFN), Blackboxstocks Inc. (Nasdaq – BLBX) - TradingView
Optinose to be acquired by Boston-based Paratek Pharmaceuticals in potential $330M deal - The Business Journals
Piper Sandler Downgrades OptiNose to Neutral From Overweight, $9 Price Target -March 20, 2025 at 12:32 pm EDT - Marketscreener.com
Optinose Inc (OPTN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
0.69%
자본화:
|
볼륨(24시간):